13F HOLDINGS REPORT
BIOIMPACT CAPITAL LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950123-24-005704
Total Value
$622.0M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cullinan Oncology, Inc. | CGEM | 7,648,268 | $130.3M | 20.95% |
| 2 | Geron Corporation | GERN | 10,475,675 | $34.6M | 5.56% |
| 3 | Iovance Biotherapeutics Inc | IOVA | 2,200,000 | $32.6M | 5.24% |
| 4 | Zentalis Pharmaceuticals, Inc. | ZNTL | 1,516,183 | $23.9M | 3.84% |
| 5 | iTeos Therapeutics, Inc. | 46565G104 | 1,745,943 | $23.8M | 3.83% |
| 6 | Sutro Biopharma, Inc. | STRO | 4,096,619 | $23.1M | 3.72% |
| 7 | Crinetics Pharmaceuticals Inc. | CRNX | 480,588 | $22.5M | 3.62% |
| 8 | Olema Pharmaceuticals, Inc. | OLMA | 1,953,690 | $22.1M | 3.56% |
| 9 | Madrigal Pharmaceuticals inc | MDGL | 61,399 | $16.4M | 2.64% |
| 10 | Natera Inc | NTRA | 172,413 | $15.8M | 2.54% |
| 11 | Werewolf Therapeutics, Inc. | HOWL | 2,388,011 | $15.5M | 2.49% |
| 12 | Moonlake Immunotherapeutics | MLTX | 296,050 | $14.9M | 2.39% |
| 13 | Avadel Pharmaceuticals PLC | 05337M104 | 871,149 | $14.7M | 2.37% |
| 14 | Insmed Incorporated | INSM | 530,794 | $14.4M | 2.32% |
| 15 | ALX Oncology Holdings Inc. | ALXO | 1,268,471 | $14.1M | 2.27% |
| 16 | VIKING THERAPEUTICS INC | VKTX | 150,000 | $12.3M | 1.98% |
| 17 | Intellia Therapeutics, Inc. | NTLA | 432,598 | $11.9M | 1.91% |
| 18 | REGENXBIO Inc. | RGNX | 549,078 | $11.6M | 1.86% |
| 19 | Ultragenyx Pharmaceutical Inc | RARE | 245,590 | $11.5M | 1.84% |
| 20 | MORPHIC HOLDING INC | 61775R105 | 325,333 | $11.5M | 1.84% |
| 21 | 89Bio Inc | 282559103 | 967,742 | $11.3M | 1.81% |
| 22 | Viridian Therapeutics Inc | VRDN | 614,010 | $10.8M | 1.73% |
| 23 | Fulcrum Therapeutics Inc | FULC | 1,137,108 | $10.7M | 1.73% |
| 24 | Xeris Biopharma Holdings Inc | XERS | 4,166,496 | $9.2M | 1.48% |
| 25 | Axsome Therapeutics, Inc. | AXSM | 114,127 | $9.1M | 1.46% |
| 26 | Kalvista Pharmaceuticals Inc | KALV | 760,722 | $9.0M | 1.45% |
| 27 | Revolution Medicines, Inc. | RVMDW | 273,217 | $8.8M | 1.42% |
| 28 | Verve Therapeutics, Inc | 92539P101 | 638,163 | $8.5M | 1.36% |
| 29 | Amicus Therapeutics Inc. | FOLD | 718,970 | $8.5M | 1.36% |
| 30 | Akero Therapeutics Inc | 00973Y108 | 332,924 | $8.4M | 1.35% |
| 31 | Adaptimmune Therapeutics plc | ADTI | 5,095,912 | $8.1M | 1.29% |
| 32 | Edgewise Therapeutics Inc | EWTX | 441,259 | $8.0M | 1.29% |
| 33 | Repare Therapeutics, Inc. | 760273102 | 1,639,849 | $7.7M | 1.24% |
| 34 | Relay Therapeutics Inc. | RLAY | 832,017 | $6.9M | 1.11% |
| 35 | Disc Medicine Inc | IRON | 110,779 | $6.9M | 1.11% |
| 36 | Trevi Therapeutics Inc | TRVI | 1,340,960 | $4.6M | 0.74% |
| 37 | Immatics NV | IMTX | 395,237 | $4.2M | 0.67% |
| 38 | Compass Therapeutics, Inc. | CMPX | 1,971,402 | $3.9M | 0.63% |